A number of analogs of a new antineoplastic agent, 1-(m-ethoxymethyloxyphenyl)-1-nonen-3-one (IIIa) were prepared and evaluated against murine P-388 lymphocytic leukemia. Metabolic studies of IIIa in rats showed that it was sequestered rapidly to the brain and hence probably to other adipose tissue, which may account for the absence of IIIa and metabolites in urine and feces. A detailed toxicological
制备了许多新型
抗肿瘤药类似物1-(间乙氧基
甲氧基苯基)-
1-壬烯-3-酮(IIIa),并评估了其对小鼠P-388淋巴细胞白血病的抵抗力。大鼠中IIIa的代谢研究表明,它被快速隔离到大脑,因此很可能被隔离到其他脂肪组织,这可能是尿液和粪便中不存在IIIa和代谢产物的原因。对大鼠IIIa进行的详细毒理学评估表明,由于从腹部出血引起的红细胞吞噬作用,主要在肝脏和脾脏中出现了明显的病理变化。